AMP Robotics Corporation specializes in designing and manufacturing robotic systems for material recovery facilities and recycling operations, focusing on automating the identification, sorting, and processing of complex waste streams. The company's flagship product, AMP Cortex, utilizes advanced robotics and computer vision technology to efficiently pick and sort recyclable materials, significantly lowering sorting costs. Additionally, AMP Neuron, a software solution, captures and analyzes material data to identify features in a manner similar to human perception. By leveraging artificial intelligence and machine learning, AMP Robotics enhances recycling processes for various waste types, including municipal solid waste and e-waste. The modular design of its systems allows for easy integration into existing infrastructure, minimizing disruption and capital investment. Founded in 2014 and headquartered in Louisville, Colorado, AMP Robotics has formed strategic partnerships to further its mission of improving recycling rates and economic recovery of recyclables.
Cerevance LLC is engaged in the development of therapeutics targeting specific proteins expressed selectively in brain cell types affected by neurological diseases. The company utilizes its proprietary NETSseq platform to profile distinct brain cell types, such as neurons and glial cells, in mature human brain tissue. This technology reveals transcriptional and epigenetic differences, facilitating the early detection and treatment of serious neurological and psychiatric disorders, including Alzheimer’s and Parkinson’s diseases. Founded in 2016, Cerevance is headquartered in Boston, Massachusetts, with an additional office in Cambridge, United Kingdom. The company's focus is on advancing new medicines for central nervous system diseases by addressing the underlying mechanisms of neurodegeneration and related conditions.
Flatfile Inc. offers a platform designed to streamline the data onboarding process for businesses by allowing developers to validate, map, and import data from various web applications. Founded in 2018 and based in Denver, Colorado, the company's key products include Portal, an import button that integrates seamlessly into software applications through a JavaScript snippet, and Concierge, which provides secure workspaces for collaboration on data ingestion challenges. Flatfile's platform supports multiple file formats, including CSV, XLS, and TSV, and features a JavaScript configurator that enables users to define target models for data validation. This automation helps organizations manage and structure imported data effectively, reducing the time spent on data cleaning and allowing teams to focus on utilizing their data for decision-making.
FinTech, RegTech, Fraud Operating System
Merlin Labs is building an autonomous infrastructure for the sky above us, enabling goods, and eventually people, to fly without pilots.
Medalion helps hospitals to empower their practice for market expansion while maintaining compliance.
Courier provides an API that enables developers to manage and route user notifications across various communication channels, such as email and messaging platforms. By leveraging user engagement data and online status, the API optimizes notification delivery, ensuring that messages reach users through the most effective medium. The company's notification management software allows clients to create reusable messages that can be customized for different channels, facilitating timely and targeted communication. Over the years, Courier has adapted to technological advancements while maintaining a stable management approach, emphasizing the importance of customer success. The company has developed long-lasting relationships with its largest clients, continually collaborating to meet their evolving needs.
Sesame, Inc., operating as SesameCare, is a company that offers a platform for booking doctor appointments and accessing medical care. Founded in 2018 and based in New York, SesameCare aims to simplify the healthcare experience by connecting patients directly with doctors, providing upfront pricing and clear descriptions of medical services. This approach is particularly beneficial for uninsured individuals or those opting to pay out-of-pocket, as it addresses common issues such as hidden costs and unexpected charges that often complicate healthcare access. By focusing on transparency and affordability, SesameCare endeavors to make quality healthcare more accessible for all patients.
Nava is a New York-based company that specializes in health insurance brokerage services aimed at delivering high-quality, affordable healthcare solutions to employers and their employees. The firm provides a range of healthcare tools, year-round employee advocacy, and continuous measurement to assess and recommend healthcare plans. By focusing on these aspects, Nava helps clients manage their employee benefits effectively while reducing overall plan costs. This approach allows businesses to offer the necessary benefits to their workforce, ensuring both accessibility and affordability in healthcare coverage.
FarmWise Labs, Inc. develops innovative robotic machinery aimed at enhancing agricultural efficiency. Founded in 2016 and based in San Francisco, the company specializes in autonomous cultivation solutions, particularly focusing on weeding and thinning crops. FarmWise's technology utilizes machine learning and artificial intelligence to perform essential farming tasks such as weeding, planting, sowing, and soil tilling. Their autonomous vegetable weeder is designed to minimize the use of herbicides, allowing farmers to cultivate healthier crops while improving overall productivity. By streamlining farm operations, FarmWise aims to support sustainable farming practices and increase food production efficiency.
Gametime United, Inc. develops a mobile application to book tickets. The company’s application enables users to buy and sell tickets for NBA, NHL, MLB, MLS, NCAA, and NFL teams. It offers its application for iOS and Android platforms through App Store and the Google Play Store. The company was founded in 2012 and is based in San Francisco, California.
Mirvie is a biotech company that creates precise, actionable, and non-invasive tests for maternal-fetal health. The company delivers insights to moms and families to make pregnancy safe. It was founded in 2018 by Maneesh Jain and is headquartered in South San Francisco, California, United States.
Invetx, Inc. is a biotechnology company based in Boston, Massachusetts, that specializes in developing protein-based therapeutics for animal health care. The company focuses on creating biopharmaceutical solutions that apply human biotechnology advancements to veterinary medicine. Invetx aims to build a premier innovation platform for veterinary therapeutics, collaborating with leading biotechnology firms, investors, and industry experts. Its team, which includes veterinary scientists and clinicians, is dedicated to discovering and developing a diverse portfolio of therapies and technologies. The company's vision is to enhance health outcomes for both pets and farm animals by leveraging biopharma technologies in the global animal health industry.
Aspen Neuroscience, Inc. is a biotechnology company based in San Diego, California, focused on developing induced pluripotent stem cell therapies for neurological conditions, particularly Parkinson's disease. Founded in 2018, the company aims to create patient-specific restorative cell therapies that can alter the progression of the disease. Its product pipeline includes ANPD001, an autologous neuron replacement therapy designed for sporadic Parkinson's disease, and ANPD002, a gene-edited version targeting familial forms of the disease. By integrating innovative genomic approaches with stem cell biology, Aspen Neuroscience seeks to advance the field of personalized medicine and improve treatment outcomes for patients suffering from Parkinson's disease.
OMass Technologies Ltd engages in drug discovery by applying mass spectrometry to the characterization of intact protein assemblies. The company offers biotherapeutics, membrane proteins, drug binding, and purifications guiding services. In addition, OMass Technologies Ltd offers structural mass spectrometry (MS) platforms, often referred to as native mass spectrometry, for characterizing complex protein assemblies. The company assists biotechnology and pharmaceutical companies in tackling drug targets and biotherapeutics. OMass Technologies Ltd was founded in 2016 and is based in Begbroke, United Kingdom.
Obsidian Security, Inc. is a technology company based in Newport Beach, California, specializing in cybersecurity solutions tailored for hybrid-cloud environments. Founded in 2017 by former members of renowned companies in the security sector, Obsidian Security focuses on leveraging artificial intelligence to address cyber threats. Its platform provides comprehensive services, including threat detection, breach remediation, and security hardening specifically for software as a service (SaaS) applications. The company's offerings aim to deliver intelligent identity protection and seamless security, enabling enterprises to safeguard their interconnected systems without hindering productivity. Backed by notable investors, Obsidian Security positions itself at the forefront of the evolving cybersecurity landscape.
Brightline is a technology-enabled behavioral health home for children and their families. Brightline delivers integrated care through innovative technology, virtual behavioral health services, and a collaborative care team focused on supporting children across developmental stages and their families.
Digits Financial, Inc. is a fintech company founded in 2018 and based in San Francisco, California. The company specializes in developing software that offers a real-time view of a business's finances. Its platform streamlines the creation of financial reports and transaction records, significantly reducing manual workload. By visualizing and managing financial data, Digits enhances interactions between businesses and their accountants, investors, and advisors. This innovative approach positions Digits as a key player in providing modern financial solutions for businesses.
Celsius Therapeutics is a biotechnology company focused on developing innovative medicines to treat complex diseases, including autoimmunity and cancer. Founded in 2017 and based in Cambridge, Massachusetts, the company leverages advanced techniques such as single-cell genomic analysis and machine learning to gain insights into the cellular ecosystems of diseases. By systematically applying single-cell sequencing and analyzing extensive datasets with sophisticated algorithms, Celsius Therapeutics aims to discover critical biomarkers and precision therapies that enhance patient care and enable clinicians to identify genes that play a causal role in various conditions.
LifeMine Therapeutics, Inc. is a biotechnology company focused on discovering new drug modalities from eukaryotic microbes, particularly fungi. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in New York, the company employs an integrated, genomically-enabled drug discovery platform that combines genomics, artificial intelligence, and synthetic biology. LifeMine aims to elucidate human biology and develop innovative therapeutics that target the underlying causes of serious diseases. By mining fungal biodiversity, the company seeks to create novel therapeutics designed to tackle previously intractable medical challenges, ultimately enhancing treatment options for healthcare providers.
Spotlight Therapeutics is a developer of gene editing therapeutics intended to edit specific cell populations directly in the body. The company's therapeutics are used to create next-generation programmable nucleases that can selectively target and edit cells, enabling physicians to treat their patient in an enhanced way.
Nothing is removing the barriers between people and technology to create a seamless digital future.
Redpanda is a queue for people who deal with massive data streams.
RightHand Robotics, Inc. specializes in manufacturing robotic order-picking systems designed for various industrial applications, including e-commerce, food handling, and flexible manufacturing. The company offers innovative products such as the ReFlex SF, which features a 3D-printed palm equipped with servos and compliant fingers, and the ReFlex TakkTile, a tactile sensor that enhances the robots' ability to grasp items gently and make adjustments to avoid errors. Their technology allows robots to automatically grasp a wide range of items from bins and cases, eliminating the need for extensive data-entry or parameter-tuning, thereby making the systems cost-effective and adaptable to the evolving needs of businesses. Founded in 2015, RightHand Robotics is headquartered in Cambridge, Massachusetts, with a sales and business development office located in Frankfurt, Germany.
Social Media Marketing Platform.
GENESIS Global was originally started by a team of industry leaders in the Global Financial Markets space with extensive experience in front to back trading technologies across multiple asset classes and business lines. The members of their management and advisory team have held senior global management roles at investment banks around the world and at trading technology software vendors. Extensive experience with global financial technology vendors.
They have a simple strategy, to be a global FinTech company providing best in class solutions and services which are in line with their client’s needs, goals and expectations. They have a disruptive framework technology and business model to achieve this strategy.
Homebound Inc. is a technology-driven custom home builder based in Santa Rosa, California, founded in 2017. The company specializes in constructing residential homes and offers a comprehensive range of support services, including architecture, design, financing, and insurance consultancy. Originating in response to the 2017 Northern California wildfires, Homebound aims to simplify the homebuilding process by providing a transparent and streamlined experience for homeowners. It manages the entire building journey, assisting clients from insurance negotiation and architectural design to permitting and construction. By leveraging user-friendly technology and a network of qualified building professionals, Homebound addresses the complexities and uncertainties homeowners face, particularly in the aftermath of natural disasters, enabling them to rebuild their homes more efficiently.
Ventus Therapeutics U.S., Inc. is a biopharmaceutical company based in Natick, Massachusetts, with an additional location in Montreal, Canada. Founded in 2019, it focuses on discovering and developing novel small-molecule medicines that target the innate immune system to address autoimmune diseases, inflammatory diseases, and cancer. The company employs a structural immunology platform that integrates protein engineering to elucidate molecular structures and mechanisms of action. This platform facilitates the development of precise binding and functional screening assays, as well as structure-based modeling. Ventus Therapeutics is advancing an emerging pipeline of drug programs aimed at key targets within the innate immune system, leveraging its proprietary capabilities in rational and structure-based drug design.
Pecan is an AI-based predictive analytics platform that streamlines the creation and deployment of predictive models for various business applications, including customer lifetime value, churn prediction, and market segmentation. Founded in 2016 and headquartered in Tel Aviv, Israel, Pecan eliminates the need for data preparation or engineering by directly connecting to raw data. The platform features a low-code interface and pre-built models that automate the predictive process, allowing organizations to generate and implement AI models within days, without requiring data science expertise. This comprehensive approach enables businesses to make informed decisions by predicting future outcomes and identifying actionable insights efficiently.
Censys, Inc. is a cybersecurity company specializing in internet scanning and asset identification solutions. Founded in 2017 and based in Ann Arbor, Michigan, Censys provides an internet device search engine that allows users to discover and analyze devices connected to the Internet, including computers, servers, and smart devices. The platform is utilized for various applications such as attack surface management, monitoring remote workforces, and identifying potential threats. Censys is recognized for delivering real-time visibility and risk assessments, making it a valuable resource for researchers, corporations, and government entities. The company's data-driven security solutions are employed by notable organizations, including FireEye, Google, NATO, and the U.S. Department of Homeland Security, to enhance their cybersecurity measures and proactively address threats.
Leyden Labs aims to help people live their lives to the fullest. Its platform targets commonalities of viral families to protect humanity from known and future viruses. Its portfolio of accessible intranasal product candidates may provide people with the freedom to immediately protect themselves from and prevent the spread of many strains of respiratory viruses, including ones in the influenza and coronavirus families. The Company’s energetic team of world-renown biotechnology veterans and fresh talent is dedicated to thinking differently to free humanity from the burden of respiratory viruses.
Found is dedicated to improving people’s overall wellbeing by making evidence based weight loss accessible & affordable for all.
Synthesia Ltd. develops artificial intelligence driven video production platform to create high-end videos. The company’s video synthesis platform allows to create high-end videos for many applications, including personalized advertising, corporate communications, and e-learning. Its platform synchronizes the lip movements in a video to a new dialogue track, which enables video content to be translated into foreign languages, widening distribution channels. The company was incorporated in 2017 and is based in London, United Kingdom.
Universe is a mobile-based website builder established in 2014 and headquartered in Brooklyn, New York. The platform aims to empower users to create customized websites quickly and easily, catering to the needs of small business owners and individuals who prefer mobile solutions. By offering a unique approach that eliminates complicated templates, Universe utilizes customizable website filters that allow users to arrange photos, videos, and icons on a grid pattern through a simple drag-and-drop interface. This enables users to build mobile-optimized websites in just minutes using the company's iOS app, providing them with full control over their online presence.
Upbound, Inc. is a technology company based in Seattle, Washington, that specializes in providing a multi-cloud platform which allows organizations to manage and optimize services across various public and private cloud environments. Founded in 2017, Upbound offers solutions that enable automation, cost optimization, and policy enforcement, facilitating scalable deployments and application management. Its platform empowers organizations to treat multiple disparate cloud environments as a single cohesive unit, enhancing efficiency and reducing operational costs while ensuring portability and failover capabilities.
Mabl Inc. offers an automated testing service that leverages machine learning to identify regressions and automatically fix broken tests. Founded in 2016 and based in Boston, Massachusetts, the company provides a scriptless testing solution as part of its software-as-a-service (SaaS) offerings. Mabl facilitates machine-driven regression testing and integrates seamlessly into the continuous integration and continuous delivery (CI/CD) development lifecycle. Its platform allows software development teams to create, execute, and maintain auto-healing tests efficiently, ensuring the rapid delivery of high-quality applications. Mabl serves a range of enterprise clients, including Johnson Controls, Liberty Mutual, Molina Healthcare, JetBlue, Dollar Shave Club, and Charles Schwab, who rely on its services for testing their critical applications.
Provider of cancer therapy services intended to improve both the safety and efficacy of cytokine immunotherapies for cancer patients. The company's services offer systemic dosing of these immune stimulants that have historically been limited by broad immune activation and toxicity, develops cancer therapies based on tumor-localized immune potentiating agents that boost anti-tumor immune responses, enabling patients to find an instant treatment for cancer without any surgery.
Developer of a healthcare AI communication tool designed to automate communication. The company's tool handles tedious, time-consuming phone calls with accuracy and easy-to-track updates, facilitates users to seamlessly submit call requests to the system and adds their tasks to the queues, enabling users to get notified as soon as each task completes or bulk-collect their results whenever needed.
Yellowbrick Data, Inc. is a technology company founded in 2014 and headquartered in Palo Alto, California, with additional offices in Salt Lake City, Hong Kong, and London. The company specializes in developing and deploying data warehouse solutions, offering both on-premises and cloud-based options. Its platform is designed to efficiently store, transform, and analyze large volumes of business data, enabling organizations to run complex mixed workloads and support numerous concurrent users. Yellowbrick’s data warehouse allows for seamless analytics across various environments, including private and public clouds, while delivering superior performance and cost-effectiveness. By addressing challenges such as high availability and scalability, Yellowbrick Data empowers enterprises to make faster, data-driven decisions.
Multiverse offers apprenticeship opportunities tailored for non-graduate individuals, positioning itself as an alternative to traditional university education. Founded in 2016 and based in London, the company focuses on providing career-oriented apprenticeships that empower young people to take charge of their professional journeys. By facilitating access to high-quality training and resources, Multiverse aims to create a fulfilling career path for its participants, moving away from conventional corporate training methods. The company also incorporates digital tools to help apprentices build their profiles and engage in social networking, enhancing their learning experience and career prospects.
strongDM manages and audits access to servers and databases. It provides a single platform to control access to any database for employees, vendors, and cloud-based tools.
The company was awarded in the Strata+Hadoop World Audience Favorite in 2016.
It was incorporated in 2015 and is headquartered in Burlingame, California.
ROME Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative therapies for cancer and autoimmune diseases. Established in 2019, ROME Therapeutics is pioneering the exploration of the repeatome, which consists of extensive regions of genetic material previously considered "junk DNA." The company has identified several drug targets and is actively advancing multiple discovery programs. To facilitate its research, ROME has assembled a team of experts across various disciplines, including oncology, immunology, virology, and machine learning, to harness this uncharted area of biology for therapeutic advancements.
Genome Medical, Inc. is a national telegenomics company that specializes in providing genetic consultation and medical consulting services. Incorporated in 2016 and based in South San Francisco, California, the company utilizes its Genome Care Delivery technology platform to deliver genetic solutions across various clinical areas, including cancer, cardiovascular health, reproductive health, pediatrics, and pharmacy. By leveraging a nationwide network of genetic specialists, Genome Medical offers expert virtual genetic care to individuals and families, enhancing their health and well-being. The company also assists healthcare providers and patients in navigating the expanding field of genetics, enabling them to interpret test results, assess disease risk, expedite diagnoses, make informed treatment choices, and reduce healthcare costs.
Ultromics Limited, founded in 2017 and based in Oxford, United Kingdom, specializes in developing advanced echocardiography software aimed at enhancing the diagnosis of coronary heart disease. The company leverages artificial intelligence to create diagnostic tools that significantly improve the accuracy of echocardiography, with reported enhancements exceeding 90%. Ultromics' technology focuses on analyzing complex data from electrocardiograms, enabling healthcare providers to make informed decisions in diagnosing coronary artery disease. By providing innovative solutions for cardiologists, Ultromics aims to transform cardiovascular diagnostics and improve patient outcomes.
Snorkel AI, Inc. is a technology company that specializes in developing an end-to-end machine-learning platform aimed at facilitating the creation, management, and monitoring of AI applications. Central to its offerings is Snorkel Flow, a data-first platform that enables users to programmatically label and augment training data, manage data for AI purposes, and deploy various machine learning models. The platform is particularly effective in extracting entities and structured information from complex documents, making it valuable across multiple sectors, including finance, government, telecommunications, healthcare, and e-commerce. Snorkel AI's innovative approach incorporates weak supervision technology, allowing both developers and non-developers to focus on data-related tasks efficiently. Founded in 2016 and headquartered in Palo Alto, California, Snorkel AI also contributes to the academic community by publishing peer-reviewed research on its core technologies.
Sonoma Biotherapeutics develops adoptive Treg cell therapies aimed at treating autoimmune and degenerative diseases. The company employs advanced genome editing and target-specific cell therapy to create therapeutic solutions that promote self-tolerance and mitigate harmful inflammatory responses associated with conditions such as rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis, amyotrophic lateral sclerosis, and Alzheimer's disease. Founded in 2019 and headquartered in South San Francisco, California, with an additional office in Seattle, Washington, Sonoma Biotherapeutics combines expertise in Treg biology and proprietary methodologies to advance its therapeutic platform, focusing on developing disease-modifying and potentially curative treatments.
Neuralink Corp. is a neural technology company focused on developing brain-computer interfaces (BCIs) that facilitate direct communication between the human brain and computers. Founded in 2016 and headquartered in San Francisco, California, with an additional office in Burlingame, the company aims to create implants that can treat brain injuries and trauma. Neuralink's innovative approach includes a concept referred to as a "neural lace," which would be surgically integrated into the brain, enabling users to interact with computers without the limitations of traditional input methods like keyboards and mice. The company is also exploring the potential of brain interfaces to alleviate symptoms of serious and chronic medical conditions, striving to enhance cognitive capabilities and keep pace with advances in artificial intelligence.
TMRW Life Sciences is a developer of a cryo-storage platform intended to improve the success rates of assisted reproductive technology. The company's platform offers an in-clinic robotic storage system and a fully digital chain of custody from clinic to offsite longterm storage, continuous remote and local monitoring and electronically integrated processes characterized by digital health signals received from every oocyte and embryo daily, enabling clients to streamline embryology lab operations, eliminate manual steps and integrates digital quality control.
Resolution Games AB is a gaming studio based in Stockholm, Sweden, founded in 2015. The company specializes in developing virtual reality (VR) and augmented reality (AR) games, aiming to create immersive experiences for players. With a team of industry experts, Resolution Games focuses on producing a diverse catalog of titles that enhance the sense of presence and engagement through cutting-edge technology. The studio's games are designed to be available across multiple platforms, catering to a wide audience of gaming enthusiasts.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
Instawork operates an online job marketplace designed to connect hospitality businesses with qualified workers. The platform automates the recruitment process, allowing businesses to fill job shifts on demand while enabling professionals to choose work that fits their schedules. By streamlining traditional recruiting methods, Instawork creates economic opportunities for both local businesses and workers. The company is rapidly expanding its reach across the United States, focusing on meeting the evolving needs of the hospitality sector.
Physna LLC is a software company based in Cincinnati, Ohio, founded in 2015. It specializes in developing a geometric search engine that enhances computer-aided design (CAD) and 3D printing processes. The platform utilizes proprietary algorithms and advanced geometric deep learning technology to transform 3D models into a structured data format, facilitating comparison and analysis for quality control and automated inspection. Physna's solutions are applicable across various industries, including manufacturing, aerospace, defense, and consumer goods, enabling clients to improve efficiency, reduce costs, and streamline inspection automation. The company's innovative approach effectively bridges the gap between physical objects and digital representations, contributing to advancements in design and manufacturing.
Kindbody is a health and technology company focused on providing comprehensive fertility services tailored for modern women. Their offerings include intrauterine insemination, in-vitro fertilization, egg and embryo freezing, as well as support for donors. In addition to fertility treatments, Kindbody provides a range of holistic health services, including maternity care, gynecology, and wellness support. By leveraging modern technology, Kindbody aims to improve access to affordable healthcare, ensuring that women can receive quality services that enhance their overall health and wellbeing.
Vercel Inc. is a cloud platform that specializes in on-demand deployment, hosting, and sharing services for frontend applications. Founded in 2015 and based in Walnut, California, the company provides automated deployment solutions integrated with GitHub, Bitbucket, and GitLab, allowing projects to be deployed seamlessly from pull requests and merge requests. Vercel's platform is designed to enhance the development and deployment experience for frontend teams by hosting static websites and serverless functions that align with the Jamstack deployment model. This model ensures that web pages are pre-rendered and can be efficiently served by a content delivery network, delivering optimal performance for developers. Vercel was formerly known as ZEIT, Inc. before rebranding in April 2020.
Sense is an automated communication and engagement platform specifically designed for enterprise recruiting teams and the staffing industry. The platform aims to enhance talent engagement by providing tools that help reduce turnover and increase re-deployment rates. It offers a real-time, comprehensive view of consultants, enabling organizations to better understand their workforce dynamics. Based in San Francisco, Sense has attracted investment from notable venture capital firms, including Accel, GV, Khosla Ventures, Signia Ventures, and IDG SF.
Brightline is a technology-enabled behavioral health home for children and their families. Brightline delivers integrated care through innovative technology, virtual behavioral health services, and a collaborative care team focused on supporting children across developmental stages and their families.
Ribon Therapeutics, Inc. is a biotechnology company based in Lexington, Massachusetts, founded in 2015. The company is focused on developing innovative cancer therapies that target monoPARP proteins, which are essential regulators of cancer cell survival. Ribon's scientific founders have made significant contributions to the understanding of PARPs, or poly(ADP-ribose) polymerases, and their roles in cancer. Leveraging this expertise, Ribon is establishing a proprietary drug discovery platform aimed at exploring the molecular actions and biological functions of monoPARPs. This platform supports the creation of a pipeline of therapeutics that selectively target these proteins to potentially treat cancer and other diseases. Ribon Therapeutics is supported by notable life science investors, enhancing its capability to advance its research and development efforts.
The Pill Club is a healthcare service that specializes in delivering birth control and related products across the United States. Founded in 2014 and based in California, it operates as an online retailer and pharmacy, providing a convenient way for women to access birth control, emergency contraceptives, and wellness gifts. The Pill Club is supported by a team of medical professionals and aims to empower women by facilitating personalized healthcare experiences. It offers prescription services in 34 states and Washington D.C., ensuring widespread access to its products. With a focus on women's health and well-being, the company strives to enhance personal freedom and health ownership through its innovative telemedicine approach.
PostHog is increasing the number of successful products in the world. We do that by providing a platform for open-source product analytics. This helps software teams understand user behaviour. We took part in Y Combinator’s W20 cohort, and had the most successful B2B software launch on HackerNews since 2012, with a product that was just 4 weeks old. Our team is a combination of former CTOs and YC founders all turned developers, alongside some of the best developers from the world's largest tech companies who have the experience to help us handle scalability. We're all remote, and we've raised enough to pay top of market. We are proudly backed by some of the best VCs and Investors in the world, such as Y Combinator. We believe in product-led growth, while we build something awesome and let our product bring the users, rather than an outbound sales team and regular cold calls. Check out posthog.com/careers if you want to be part of this journey.
Lovevery, Inc. is a company based in Boise, Idaho, that specializes in manufacturing educational play products for infants. Founded in 2015, Lovevery offers a range of items designed to support early childhood development, including the Play Gym, which features various toys and tools that engage babies' senses and promote learning at different developmental stages. The company's products are informed by child development experts and aim to provide parents with stage-based information to enhance their children's growth. Lovevery sells its offerings primarily online and has received recognition for its innovative designs from several notable organizations, including TIME Magazine and Parents' Choice. The company is backed by prominent investors such as Maveron and the Chan Zuckerberg Initiative.
Clear Labs, Inc. is a food analytics company based in Menlo Park, California, founded in 2013. The company offers a comprehensive food analytics platform that utilizes next-generation sequencing to analyze the molecular contents of foods and ingredients. This platform provides food manufacturers, suppliers, and retailers with crucial transparency across supply chains, testing products for authenticity, contaminants, allergens, and various other factors such as GMOs, heavy metals, and nutrition. Clear Labs also focuses on simplifying complex diagnostics for clinical and applied markets, combining DNA sequencing, robotics, and cloud-based analytics to improve accuracy and accelerate outcomes. By delivering insights into food safety and quality, Clear Labs aims to enhance understanding and management of potential health risks associated with food products and emerging pathogens.
Merlin Labs is building an autonomous infrastructure for the sky above us, enabling goods, and eventually people, to fly without pilots.
Bowery Farming Inc. is a modern agricultural company based in New York City, specializing in the cultivation of post-organic produce such as baby kale, lettuce, arugula, and basil. Founded in 2014, Bowery employs advanced technology, including its proprietary BoweryOS software, to create optimal growing conditions in indoor farms. This system utilizes automation, machine learning, and vision systems to monitor plant growth continuously, resulting in highly efficient farming practices. Bowery's operations use zero pesticides and consume 95% less water while achieving over 100 times the productivity of traditional farming methods on the same land area. The company sells its products through grocery stores, including select Whole Foods and Foragers locations, and supplies produce to various restaurants, including those owned by renowned chef Tom Colicchio. Bowery Farming is committed to transforming agriculture to ensure a sustainable and healthier food supply for the future.
Overture Life, Inc. is a New York-based company that specializes in developing robotic technologies for in vitro fertilization (IVF) applications. Founded in 2017, Overture Life aims to transform embryology through its innovative reproduction automation technology. The company's products focus on automating key processes in IVF, including devices for automated cryopreservation and embryo testing services. These advancements enable fertility clinics to identify viable embryos prior to implantation, thereby assisting individuals and couples in their efforts to conceive.
OneNav is a technology company based in Palo Alto, California, co-founded by Stephen Poizner and Paul McBurney in 2019. The company specializes in developing a mobile positioning system tailored for smartphones, wearables, and IoT tracking devices. Utilizing the modernized L5 signaling band from navigation satellite constellations and incorporating artificial intelligence, OneNav's system delivers enhanced, data-rich signals that ensure accurate and reliable tracking applications for its clients.
Smol Limited, established in 2017 and based in Crawley, United Kingdom, specializes in the manufacturing of eco-friendly laundry capsules, dishwasher tablets, and fabric conditioners. The company operates primarily through a subscription model, delivering its products directly to customers' homes via letterboxes, which enhances convenience and accessibility. Smol's offerings are designed to be compact, water-soluble, and made from recycled materials, providing an environmentally friendly alternative to conventional cleaning products. By undercutting the prices of leading brands, Smol aims to deliver effective cleaning solutions while promoting sustainable practices in household cleaning.
Headway is a New York-based mental healthcare system provider that connects patients with therapists through a health insurance advisory platform. Founded in 2019 by Andrew Adams, Jake Sussman, Dan Ross, and Kevin Chan, the company aims to make mental healthcare more accessible and affordable. It operates a virtual network of therapists who accept insurance, allowing patients to schedule video or in-person sessions online. In addition to its mental health services, Headway also offers administrative support to therapists who typically do not accept insurance, thereby facilitating the expansion of their practices. By streamlining the connection between patients and providers, Headway seeks to improve the overall accessibility of mental health services.
Affinia Therapeutics Inc. is a biotechnology company focused on developing gene therapies for various diseases, particularly those affecting muscle and the central nervous system (CNS). Founded in 2019 and based in Waltham, Massachusetts, the company specializes in creating rationally designed adeno-associated virus (AAV) vectors. By integrating synthetic and systems biology with high-throughput screening and advanced resolution techniques, Affinia Therapeutics aims to address significant unmet medical needs. The company’s innovative approach allows for the development of novel gene therapies with enhanced properties, targeting the treatment of devastating diseases and improving the lives of affected individuals.
Outlier.org Inc. develops an online educational platform. It offers Outlier.org, a platform that provides online courses on calculus and psychology. The company’s platform also provides video content, online textbooks, one-on-one tutoring, artificial intelligence-proctored assessments, problem sets, and active learning techniques. Outlier.org Inc. was formerly known as Outlier School Inc. The company was incorporated in 2018 and is based in Brooklyn, New York.
Invivyd is a biotechnology company focused on developing advanced antibodies to neutralize SARS-CoV-2, SARS-CoV-1, and other potentially emerging coronaviruses. Founded in 2020 and headquartered in Waltham, Massachusetts, the company aims to create best-in-class therapeutic and prophylactic treatments that surpass the efficacy of existing antibody programs. Its innovative portfolio features multiple non-competing antibodies, each targeting distinct viral epitopes, which is designed to minimize the risk of viral escape. By leveraging cutting-edge antibody discovery technologies, Invivyd seeks to enhance the potency and durability of its antibody candidates, addressing a critical need in the ongoing fight against coronaviruses.
Tend offers personalized dental care services that emphasize patient comfort and satisfaction. The company operates dental studios that provide a comprehensive range of services, including routine checkups, implants, and veneers. Tend aims to enhance the patient experience by ensuring safety through health checks, contactless check-in, and the use of enhanced personal protective equipment. By focusing on straightforward and hassle-free dental care, Tend strives to deliver accurate diagnoses and high-quality restorations, making dental visits more efficient and enjoyable for patients.
Ventus Therapeutics U.S., Inc. is a biopharmaceutical company based in Natick, Massachusetts, with an additional location in Montreal, Canada. Founded in 2019, it focuses on discovering and developing novel small-molecule medicines that target the innate immune system to address autoimmune diseases, inflammatory diseases, and cancer. The company employs a structural immunology platform that integrates protein engineering to elucidate molecular structures and mechanisms of action. This platform facilitates the development of precise binding and functional screening assays, as well as structure-based modeling. Ventus Therapeutics is advancing an emerging pipeline of drug programs aimed at key targets within the innate immune system, leveraging its proprietary capabilities in rational and structure-based drug design.
Snorkel AI, Inc. is a technology company that specializes in developing an end-to-end machine-learning platform aimed at facilitating the creation, management, and monitoring of AI applications. Central to its offerings is Snorkel Flow, a data-first platform that enables users to programmatically label and augment training data, manage data for AI purposes, and deploy various machine learning models. The platform is particularly effective in extracting entities and structured information from complex documents, making it valuable across multiple sectors, including finance, government, telecommunications, healthcare, and e-commerce. Snorkel AI's innovative approach incorporates weak supervision technology, allowing both developers and non-developers to focus on data-related tasks efficiently. Founded in 2016 and headquartered in Palo Alto, California, Snorkel AI also contributes to the academic community by publishing peer-reviewed research on its core technologies.
Lightmatter, Inc. is an artificial intelligence (AI) hardware company based in Boston, Massachusetts, that specializes in integrated optical technology to develop advanced computing processors. Founded in 2017, the company has created a silicon chip that utilizes light signals for processing, offering a new approach to AI computation. This technology accelerates critical operations in deep neural networks by employing programmable photonic elements alongside traditional transistors, enhancing the speed and efficiency of data processing while minimizing power consumption. Lightmatter's innovations aim to improve various AI applications, including image recognition and natural language processing, contributing to the advancement of next-generation AI-powered computing solutions.
Cameo is a marketplace that enables fans to book personalized video shoutouts from a wide range of celebrities and influencers. The platform focuses on providing authentic and tailored fan experiences by allowing users to connect with their favorite personalities for custom video messages. Cameo partners with thousands of talents across various fields, offering customers an opportunity to share unique, personalized content. The company's mission centers on enhancing fan engagement through these bespoke interactions, creating memorable experiences that resonate with users. Based in Chicago, Cameo is a key player in the technology and startup ecosystem, facilitating a creative outlet for both fans and celebrities.
Insitro, Inc. is a data-driven drug discovery and development company based in South San Francisco, California, founded in 2018. The company utilizes machine learning and high-throughput biology to transform the traditional processes of drug discovery and delivery. By generating extensive functional genomic datasets and aligning them with patient data through innovative machine learning techniques, Insitro builds predictive models that aim to address critical challenges in pharmaceutical research and development. These models facilitate accelerated target selection and the design of effective therapeutics, ultimately enhancing the efficiency of drug development and informing clinical strategies. The focus of Insitro's work includes the treatment of nonalcoholic steatohepatitis (NASH), showcasing its commitment to addressing significant health issues through advanced technology.
GENESIS Global was originally started by a team of industry leaders in the Global Financial Markets space with extensive experience in front to back trading technologies across multiple asset classes and business lines. The members of their management and advisory team have held senior global management roles at investment banks around the world and at trading technology software vendors. Extensive experience with global financial technology vendors.
They have a simple strategy, to be a global FinTech company providing best in class solutions and services which are in line with their client’s needs, goals and expectations. They have a disruptive framework technology and business model to achieve this strategy.
Monte Rosa Therapeutics is a biotechnology company based in Basel, Switzerland, that specializes in developing innovative cancer therapeutics through the modulation of protein degradation pathways. The company focuses on molecular glue degraders (MGDs), a class of small molecule drugs that utilize the body's natural mechanisms for protein degradation to selectively target and degrade proteins relevant to cancer treatment. Monte Rosa employs its QuEEN platform, which integrates artificial intelligence and proprietary experimental tools, to identify and develop target proteins for degradation. With a library of over 50,000 MGD molecules, its leading product candidate, MRT-2359, specifically targets the translation termination factor protein GSPT1, showing potential for treating MYC-driven tumors. The company is committed to advancing its pipeline of novel therapeutics to address unmet medical needs in oncology.
Tenaya Therapeutics is a biotechnology company based in South San Francisco, California, focused on developing innovative therapies for heart disease, particularly heart failure. Established in 2016, the company employs three main platforms to address the underlying causes of heart disease: a cellular regeneration platform that reprograms cardiac fibroblasts into cardiomyocytes using proprietary transcription factors, a gene therapy platform for targeted delivery of therapeutic payloads, and a precision medicine approach tailored to individual patients. Through these platforms, Tenaya Therapeutics aims to enable the regeneration of heart tissue and tackle various forms of cardiomyopathies, leveraging advanced research in cardiac development and regeneration.
Nanit is a company that specializes in developing advanced monitoring devices utilizing artificial intelligence and computer vision to track and analyze baby sleep behavior and patterns. Their innovative products include a camera that provides real-time monitoring and analysis of sleep, offering parents valuable insights, behavioral analysis, expert advice, and nightly video summaries. This technology is designed to enhance the parenting experience by delivering smarter and safer solutions for caring for infants. The Nanit team is composed of experts from diverse backgrounds, including scientists, designers, and professionals from prominent companies, all dedicated to creating tools that support parents during the early months of a child's life.
Evox Therapeutics is a biotechnology company based in Oxford, United Kingdom, focused on developing exosome-based therapeutics for the treatment of severe diseases. Founded in 2016, the company leverages its proprietary technology to harness and engineer extracellular vesicles, known as exosomes, for the targeted delivery of nucleic acids and proteins. This innovative approach aims to enhance drug delivery to challenging areas, such as the brain and central nervous system, where conventional therapies often fall short. Evox’s mission is to improve human health by creating novel therapeutics that address significant medical needs, particularly for conditions with limited treatment options. The company has built a comprehensive intellectual property portfolio and is backed by prominent life sciences venture capital groups, positioning it as a leader in the emerging field of exosome-based drug delivery.
Dandelion Energy, Inc., founded in 2017 and headquartered in Palo Alto, California, specializes in affordable geothermal heating and cooling solutions for residential properties. The company's innovative home geothermal system replaces traditional air conditioning and heating equipment with a heat pump and underground pipes that efficiently transfer thermal energy between the earth and the home. This proprietary installation process allows homeowners to transition from conventional heating fuels to renewable geothermal energy, providing an environmentally friendly and cost-effective alternative for temperature regulation and hot water production.
TScan Therapeutics is a biopharmaceutical company dedicated to developing innovative T cell therapies to treat various cancers, including liquid tumors and solid tumors. The company focuses on engineering T cell receptor (TCR) therapies, with specific candidates aimed at addressing hematologic malignancies and preventing relapse after hematopoietic stem cell transplantation. TScan utilizes a specialized platform that identifies shared T cell antigens and minimizes off-target effects, enhancing the safety and effectiveness of its treatments. The company’s pipeline includes both liquid tumor therapies and multiplexed TCR-T candidates for solid tumors. Founded in 2018, TScan Therapeutics is headquartered in Waltham, Massachusetts, and comprises a team of experts committed to expanding treatment options for patients with limited therapeutic alternatives.
Vera Therapeutics is engaged in the development of innovative gene editing solutions aimed at curing genetic diseases, particularly sickle cell disease and cystic fibrosis. The company utilizes a proprietary triplex gene editing platform to create a pipeline of therapeutic products targeting high-penetrance disease genes. Founded in 2016 and based in South San Francisco, California, Vera Therapeutics is dedicated to alleviating and potentially curing genetic disorders in affected patients.
Verve Therapeutics is a biotechnology company focused on developing innovative therapies aimed at editing the adult human genome to provide lifelong protection against coronary artery disease, a leading global cause of mortality. Founded in 2018 and based in Cambridge, Massachusetts, with a research facility in Philadelphia, the company employs gene-editing technology to create treatments that shift the management of cardiovascular diseases from chronic care to potentially curative interventions. Its initial programs concentrate on the PCSK9 and ANGPTL3 genes, which are recognized for their roles in regulating blood lipids, specifically low-density lipoprotein cholesterol. Verve Therapeutics collaborates with partners such as Beam Therapeutics and Verily to enhance delivery technologies for its cardiovascular treatments.
Multiverse offers apprenticeship opportunities tailored for non-graduate individuals, positioning itself as an alternative to traditional university education. Founded in 2016 and based in London, the company focuses on providing career-oriented apprenticeships that empower young people to take charge of their professional journeys. By facilitating access to high-quality training and resources, Multiverse aims to create a fulfilling career path for its participants, moving away from conventional corporate training methods. The company also incorporates digital tools to help apprentices build their profiles and engage in social networking, enhancing their learning experience and career prospects.
EQRx operates as a biotechnology company, focused on re-engineering the process from drug discovery to patient delivery with the goal of offering a market-based solution for the rising cost of medicines. By bringing together stakeholders from across the healthcare system and utilizing the latest advances in science and technology, the company seeks to discover, develop and deliver high-quality, patent-protected medicines more efficiently and cost-effectively than ever before.
The company was founded in 2019 and is based in Cambridge, Massachusetts, United States.
LifeMine Therapeutics, Inc. is a biotechnology company focused on discovering new drug modalities from eukaryotic microbes, particularly fungi. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in New York, the company employs an integrated, genomically-enabled drug discovery platform that combines genomics, artificial intelligence, and synthetic biology. LifeMine aims to elucidate human biology and develop innovative therapeutics that target the underlying causes of serious diseases. By mining fungal biodiversity, the company seeks to create novel therapeutics designed to tackle previously intractable medical challenges, ultimately enhancing treatment options for healthcare providers.
FogPharma is a healthcare company founded in 2015 and headquartered in Gloucester, Massachusetts. The firm is dedicated to the pharmaceutical sector, with a primary focus on developing innovative treatments for cancer. It operates with the support of a diverse group of private and institutional investors, fostering collaboration among its founders, employees, and advisors. FogPharma aims to create a new class of medicines designed to extend and enhance the lives of cancer patients. The company's commitment to its mission drives its efforts to pioneer effective solutions in cancer treatment.
AMP Robotics Corporation specializes in designing and manufacturing robotic systems for material recovery facilities and recycling operations, focusing on automating the identification, sorting, and processing of complex waste streams. The company's flagship product, AMP Cortex, utilizes advanced robotics and computer vision technology to efficiently pick and sort recyclable materials, significantly lowering sorting costs. Additionally, AMP Neuron, a software solution, captures and analyzes material data to identify features in a manner similar to human perception. By leveraging artificial intelligence and machine learning, AMP Robotics enhances recycling processes for various waste types, including municipal solid waste and e-waste. The modular design of its systems allows for easy integration into existing infrastructure, minimizing disruption and capital investment. Founded in 2014 and headquartered in Louisville, Colorado, AMP Robotics has formed strategic partnerships to further its mission of improving recycling rates and economic recovery of recyclables.
Encodia, Inc. engages in proteomics research and creates scalable and parallelized approaches to protein analysis. The company was founded in 2015 and is based in San Diego, California.
Vercel Inc. is a cloud platform that specializes in on-demand deployment, hosting, and sharing services for frontend applications. Founded in 2015 and based in Walnut, California, the company provides automated deployment solutions integrated with GitHub, Bitbucket, and GitLab, allowing projects to be deployed seamlessly from pull requests and merge requests. Vercel's platform is designed to enhance the development and deployment experience for frontend teams by hosting static websites and serverless functions that align with the Jamstack deployment model. This model ensures that web pages are pre-rendered and can be efficiently served by a content delivery network, delivering optimal performance for developers. Vercel was formerly known as ZEIT, Inc. before rebranding in April 2020.
Locanabio, Inc. develops RNA-targeted gene therapies to treat a spectrum of underserved diseases. It offers therapies for neuromuscular, neurodegeneration, and ophthalmology diseases. Locanabio, Inc. was formerly known as Locana, Inc. and changed its name to Locanabio, Inc. in July 2020. The company was founded in 2016 and is based in San Diego, California.
Established in 2008, HODINKEE is the destination for all things in the world of horology. Over the past decade, founder Ben Clymer and team have grown HODINKEE into a robust media and retail platform by providing its respected point of view on industry news and releases, investing in engaging and creative storytelling, producing a designated podcast, printing a bi-annual publication, and launching and growing its own retail outlet, HODINKEE Shop. At its core, HODINKEE’s goal is to bring its readers and consumers the best in luxury products in a way that is approachable, authentic, and honest.
Flock Freight Inc. specializes in less-than-truckload (LTL) freight shipping and management services across North America. The company uses innovative algorithms to pool LTL and partial-truckload shipments into full truckloads, enhancing efficiency and reducing costs for businesses. Its flagship product, FlockDirect, enables seamless transportation of pooled freight without the need for terminals, ensuring safe and direct deliveries. Additionally, Flock Freight offers a technology platform that consolidates multiple shipments into multi-stop routes, optimizing logistics for shippers and maximizing revenue opportunities for carriers. Founded in 2015 and headquartered in Solana Beach, California, Flock Freight aims to transform the LTL freight industry through advanced technology and a focus on customer experience.
Resilience is a biopharmaceutical manufacturing and technology company based in La Jolla, California, established in 2020. It aims to enhance access to complex medicines and safeguard biopharmaceutical supply chains. The company specializes in end-to-end manufacturing and development solutions across various therapeutic modalities, including cell and gene therapies, viral vectors, vaccines, and proteins. Resilience provides customized manufacturing capabilities that cater to the diverse needs of biopharmaceuticals at all stages of the drug development process, from pre-clinical development to commercial supply. With a focus on developing new manufacturing technologies, Resilience ensures high-quality and regulatory-compliant processes for complex and novel medicines.
Invivyd is a biotechnology company focused on developing advanced antibodies to neutralize SARS-CoV-2, SARS-CoV-1, and other potentially emerging coronaviruses. Founded in 2020 and headquartered in Waltham, Massachusetts, the company aims to create best-in-class therapeutic and prophylactic treatments that surpass the efficacy of existing antibody programs. Its innovative portfolio features multiple non-competing antibodies, each targeting distinct viral epitopes, which is designed to minimize the risk of viral escape. By leveraging cutting-edge antibody discovery technologies, Invivyd seeks to enhance the potency and durability of its antibody candidates, addressing a critical need in the ongoing fight against coronaviruses.
Weaveworks Limited is a software company founded in 2014, based in London with an additional office in San Francisco. The company specializes in developing open-source software that simplifies the operation of Kubernetes workloads and enhances the management of containerized applications. Its key products include Weave Net, which provides a portable software-defined networking solution; Weave Scope, enabling real-time visualization and interaction with distributed applications; Weave Flux, which automates request routing to facilitate microservices; and Weave Cloud, a Software-as-a-Service platform that supports DevOps teams in connecting, monitoring, and deploying containers and microservices. Weaveworks is recognized for its contributions to various open-source projects and aims to streamline the development and deployment processes for developers and operations teams, ultimately accelerating the delivery of cloud-native applications while minimizing operational complexity.
Superplastic, Inc. is a character-based product and entertainment company founded in 2017 and based in Burlington, Vermont. The company specializes in manufacturing and marketing limited edition art toys, apparel, games, and animation, featuring unique characters created in collaboration with renowned artists. Superplastic leverages the principles of effort and scarcity to enhance the value of its offerings, creating exclusive works of art for a select audience. The company also operates a platform that engages customers through various media, including animated videos and music, enabling interactions with its synthetic superstars in innovative ways. Products are primarily sold online, reflecting a modern approach to retail and entertainment.
Alkira, Inc. is a network cloud company that offers an end-to-end networking platform designed for hybrid and multi-cloud environments. Founded in 2018 and based in San Jose, California, Alkira provides its services through a pay-as-you-go model, allowing customers to connect their local systems and cloud workloads to the Alkira Cloud Exchange Points. The platform enables on-demand activation of security and other services that can auto-scale based on utilization. Alkira's Network Cloud solution allows businesses to easily create and manage their network infrastructure using an intuitive digital design canvas, facilitating rapid deployment. The company serves a diverse clientele, including Fortune-100 enterprises and leading managed service providers, by delivering integrated network and security services along with operational visibility and governance.